Authors: Shridhar, V Lee, J Pandita, A Iturria, S Avula, R Staub, J Morrissey, M Calhoun, E Sen, A Kalli, K Keeney, G Roche, P Cliby, W Lu, K Schmandt, R Mills, GB Bast, RC James, CD Couch, FJ Hartmann, LC Lillie, J Smith, DI

Citation: V. Shridhar et al., Genetic analysis of early- versus late-stage ovarian tumors, CANCER RES, 61(15), 2001, pp. 5895-5904

Authors: Mills, GB Schmandt, R Gershenson, D Bast, RC

Citation: Gb. Mills et al., Should therapy of ovarian cancer patients be individualized based on underlying genetic defects?, CLIN CANC R, 5(9), 1999, pp. 2286-2288

Authors: Schmandt, R Liu, SK McGlade, CJ

Citation: R. Schmandt et al., Cloning and characterization of mPAL, a novel Shc SH2 domain-binding protein expressed in proliferating cells, ONCOGENE, 18(10), 1999, pp. 1867-1879